Trial‐Based Hemolysis Modeling to Investigate Operating Modes of Continuous‐Flow LVADs
Artificial Organs · 2025
DOI: 10.1111/aor.70021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Patrick Borchers und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair for Medical Information Technology, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. Hauptthemen laut MEDLINE: Heart-Assist Devices, Hemolysis, Models, Cardiovascular. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
The influence of operating modes on pump‐induced hemolysis in continuous‐flow left ventricular assist devices (LVADs) can be assessed using computational fluid dynamics (CFD) simulations alongside power law models derived from shearing device experiments. However, this conventional method incurs high computational costs, limiting the exploration of diverse operating conditions and hindering online hemolysis prediction. This work presents a CFD‐free and trial‐based methodology for determining online‐capable hemolysis models for continuous‐flow LVADs.
Methods
The trial‐based hemolysis model is based on a modified power law model, with parameters identified from LVAD hemolysis trials. The dynamic behavior is modeled using the Lagrangian approach. Specifically, this model was determined for the Sputnik1 LVAD and integrated with a lumped‐parameter model of the LVAD‐supported cardiovascular system. Subsequently, hemolysis was predicted across various operating modes and patient conditions.
Results
The RMSE and the R 2 of the modified power law fit were 18.4 [%·mL/h] and 0.69, respectively. The relative error introduced by the Lagrangian approach was below 0.7%. For the Sputnik1, hemolysis decreased with reduced speed. Additionally, lower systemic resistance and diminished left ventricular contractility were associated with lower hemolysis, whereas speed modulation increased hemolysis across most profiles.
Discussion
The proposed hemolysis model allows to assess various LVAD operating modes and patient conditions, assisting in the selection of low‐hemolysis treatment strategies. For Sputnik1 patients, it is advisable to maintain low pump speed and systemic resistance, while speed modulation should be reserved for those with low hemolysis markers. Integrating this model with online flow sensing would enable online hemolysis prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair for Medical Information Technology, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
ORCID-Profile: Patrick Borchers
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Borchers, P., Leonhardt, S., & Walter, M. (2025). Trial‐Based Hemolysis Modeling to Investigate Operating Modes of Continuous‐Flow LVADs. Artificial Organs. https://doi.org/10.1111/aor.70021
Vancouver
Borchers P, Leonhardt S, Walter M. Trial‐Based Hemolysis Modeling to Investigate Operating Modes of Continuous‐Flow LVADs. Artificial Organs. 2025. doi:10.1111/aor.70021
BibTeX
@article{Borchers2025,
author = {Borchers, Patrick and Leonhardt, Steffen and Walter, Marian},
title = {Trial‐Based Hemolysis Modeling to Investigate Operating Modes of Continuous‐Flow LVADs},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.70021}
}
EUVIMED